reaction with . The conditions for different reactions were studied and optimized. The methods have been validated and successfully applied to the analysis of bulk drugs and their tablets with good recoveries ranging from 97.93 (±1.46) to 100.6 (±1.75) for method I, 98.49 (±1.43) to 99.86 (±0.87) for method II, and 98.98 (±1.11) to 99.90 (±0.86) for method III. No interference was observed from common pharmaceutical adjuvants. The results obtained compare well with those of reported methods.
.
Three Simple and selective spectrophotometric and spectrofluorimetric methods were developed for the quantitative determination of certain diuretics (bendroflumethiazide, benzthiazide, chlorthalidone, clopamide, hydrochlorothiazide, hydroflumethiazide, indapamide and xipamide) in pure forms as well as in their pharmaceutical formulations through their hydroxamate formation and subsequent complexation with iron (method I), reaction with potassium ferricyanide (method II) and
INTRODUCTION
Thiazide diuretics are a major class of diuretic agents that have been used for over 30 years. 1 Subsequently, drugs that are pharmacologically similar to thiazide diuretics but are not thiazides were developed and are called thiazide-like diuretics. 2&3 Many analytical procedures have been reported for the determination of the investigated drugs. The British Pharmacopoeia 1998 adopted an electrochemical method for the analysis of the studied drugs. 4 United States Pharmacopoeia USP XXV, NFXX describes titremetric, spectrophotometric and high performance liquid chromatographic methods for the analysis of the studied drugs. 5 Bendroflumethiazide has been assayed by chromatographic, 6-10 spectrophotometric [11] [12] [13] and fluorimetric 14&15 methods. Benzthiazide has been assayed by chromatographic, 16&17 spectrophotometric 18 and electrochemical 19 methods. Chromatographic 20&21 and spectrophotometric 22 methods have been used for assay of chlorthalidone. The most recent methods for determination of clopamide include chromatographic [23] [24] [25] and spectrophotometric 26 methods. Hydrochlorothiazide has been assayed by chromatographic, 27&28 spectrophotometric 29&30 and spectrofluorimetric 31 methods. Hydroflumethiazide has been assayed by chromatographic 32&33 and spectrophotometric 34&35 methods. The most recent methods for determination of indapamide include chromatographic, [36] [37] [38] spectrophotometric 39&40 and fluorimetric 41&42 methods. Xipamide has been assayed by chromatographic [43] [44] [45] and spectrophotometric 46 methods.
In continuation, we wish here to develop simple and rapid spectrophotometric and spectrofluorimetric procedures for the determination of thiazide and thiazide-like diuretics suitable for quality control purposes. The structures of the studied drugs are given in Tables 1 and 2 . 
Standard solutions For procedure I
Weigh accurately 20 mg of each drug, dissolve in 4.0 ml methanol in a 50-mL volumetric flask and complete to volume with distilled water. This stock solution (0.4 mg/mL) is diluted to contain 0.04 mglmL (in case of chlorthalidone), 0.08 mg/mL (in case of clopamide, hydroflumethiazide and xipamide) or 0.16 mg/mL (in case of benzthiazide, bendroflumethiazide, hydrochlorothiazide and indapamide).
For procedure II
Weigh accurately 20.0 mg of each drug, dissolve in 4.0 mL methanol in a 100-mL volumetric flask and complete to volume with distilled water (0.2 mg/mL).
For procedure III
Weigh accurately 20.0 mg of bendroflumethiazide, hydrochlorothiazide and hydroflumethiazide or 40.0 mg of clopamide. Dissolve in about 10.0 mL absolute ethanol in 100-mL volumetric flask and complete to the mark with the same solvent.
Procedures

Procedure I Pure drugs
Accurately measure 1.0 mL of the standard stock solution (0.4 mg/mL) into a test tube, add 1.0 mL of hydroxylamine hydrochloride and 2.0 mL of sodium hydroxide, heat for 20 minutes in a boiling water bath, cool, transfer into 10-mL volumetric flask, wash the test tube two times with portions of distilled water each of 1 mL and transfer the washings into the volumetric flask. Add 2.0 mL of hydrochloric acid and 1.0 ml of ferric chloride hexahydrate. Allow to stand for 20 minutes at room temperature (25 ± 5°), then dilute with distilled water to volume and mix well. Measure the absorbance at 500 nm against reagent blank treated similarly.
Construction of calibration graphs
Dilute the standard stock solution (0.4 mg/mL) quantitatively to give a series of concentrations, suitable for constructing the calibration graphs (final drug concentration; 0.3-4 μg/mL). Use 1.0 mL of each solution for the reaction with hydroxylamine and ferric chloride as directed under the procedure for pure drugs.
Stoichiometry
The stoichiometric ratios were determined by Job's method of continuous variation. 48 The stability constants for formed chelates were calculated.
Stability indicating properties of the assay as well as spectroscopic investigation of the products using IR and 1 H-NMR spectroscopy were studied.
Procedure II Pure drugs
Accurately measure 1.0 mL of the standard stock solution (0.2 mg/mL) into test tube, add 1.0 mL of sodium hydroxide and 1.0 mL of potassium ferricyanide, boil for 45 minutes in water bath, cool and transfer into 10-mL volumetric flask. Wash the test tube two times with portions of distilled water each of 1 mL and transfer the washings into the volumetric flask. Add 1.0 mL of hydrochloric acid, allow to stand for 20 minutes at room temperature (25 ± 5°), then dilute with distilled water to the volume and mix well. Measure the absorbance at 720 nm against reagent blank treated similarly.
Construction of calibration graphs
Dilute the standard stock solution (0.2 mg/mL) quantitatively to give a series of concentrations, suitable for constructing the calibration graphs (final drug concentration; 2-20 μg/mL). Use 1.0 mL of each solution for the reaction with potassium ferricyanide as directed under the general analytical procedure.
Stoichiometry
The stoichiometric ratios were determined by Job's method of continuous variation. 48
Procedure III Pure drugs
Accurately measure 1.0 mL of the standard solution into test tube, add 1.0 mL of 4-chloro-7-nitrobenzofurazan, heat to 60° for 45 minute in water bath, cool, transfer into 10-mL volumetric flask, then dilute with ethanol to the volume and mix well. The relative fluorescence intensities of the resulting solutions were measured at room temperature (25 ± 5°) against a reagent blank treated similarly at (excitation λ max 470 nm and emission λ max 535 nm).
Construction of calibration graphs
Dilute the standard stock solution quantitatively to give a series of concentrations suitable for constructing the calibration graphs (2-12 μg/mL). Use 1.0 mL of each solution for the reaction with 4chloro-7-nitrobenzofurazan as directed under the general analytical procedure.
Stoichiometry
The stoichiometric ratios were determined by Job's method of continuous variation. 48 
Analysis of pharmaceutical formulations
Transfer an accurately weighed amount equivalent to 50.0 mg of each drug from composite of 20 powdered tablets into a 100-mL calibrated flask. Dissolve and dilute to the mark with distilled water, sonicate for 10 minutes and filter off to obtain a solution of 1.0 mg/mL. Further dilutions with distilled water were made to obtain sample solutions, then the general procedures I, II and III were followed.
RESULTS AND DISCUSSION
Method I
The interaction of the hydroxamic acid derivatives of all studied drugs, bendroflumethiazide, benzthiazide, chlorthalidone, clopamide, hydrochlorothiazide, hydroflumethiazide, indapamide and xipamide with ferric chloride hexahydrate, in acidic medium gave a red coloured product with an absorption maximum at 500 nm. The absorption spectrum of the interaction product of ferric chloride hexahydrate with xipamide hydroxamate as a representative example for the studied drugs is shown in Figure 1 .
Factors affecting color development
A preliminary investigation was carried out to determine the optimumconditions for the hydroxamate formation and subsequent chelate formation for the studied drugs.
Effect of hydroxylamine concentration
The absorption intensity of the resulting ferric chelate was found to increase by increasing concentration of hydroxylamine and reaches its maximum value at 1.0 mL of 2.5 M per 10 mL of final solution, after which no further increase was noticed ( Fig. 2 ).
Effect of sodium hydroxide concentration
The absorption intensity of the resulting ferric chelate was found to increase by increasing concentration of sodium hydroxide and reaches its maximum value at 1.0 mL of 8.0 M per 10 mL of final solution, after which no further increase was noticed. Higher concentrations are not recommended to avoid addition of more hydrochloric acid because the reaction was performed in acidic medium ( Fig. 3 ).
Effect of temperature
The intensity of absorption of the resulting ferric chelates increases on increasing temperature upon interaction of the drugs with hydroxylamine and sodium hydroxide to form hydroxamic acids, the best results were obtained at boiling point (100°).
Effect of time of boiling
The intensity of absorption of the resulting ferric chelates increases on increasing time of heating the drug with hydroxylamine and sodium hydroxide to form hydroxamic acid. Optimum reaction time was attained after 20 minutes for all the studied drugs ( Fig. 4 ).
Effect of hydrochloric acid concentration
The absorption intensity of the resulting ferric chelates increases by increasing concentration of hydrochloric acid and reaches its maximum value at 1.0 mL of 8.0 M per 10 mL of final solution, after which the absorption intensity decreases ( Fig. 5 ).
Effect of ferric chloride concentration
The absorption intensity of the resulting ferric chelate increases by increasing concentration of ferric chloride and reaches its maximum value at 1.0 mL of 0.5 M per 10 mL of final solution, after which no further increase was noticed. Higher concentrations are not recommended to avoid high absorption intensity of the reagent blank ( Fig. 6 ).
Effect of chelate development time
The optimum chelation reaction time was determined by following the colour development at room temperature (25 ± 5°) at 500 nm. The reaction of ferric chloride with each of the hydroxamate of the studied drugs exhibits higher colour intensity when the reaction mixture was diluted to the volume directly before measurement. Optimum reaction time was attained after 20 minutes for all the studied drugs and the colour remained stable for further 15 minutes for all the studied drugs ( Fig. 7 ). 
Quantitative parameters
The regression equations were derived using the least-squares method. The intercepts (a), slopes (b), correlation coeffecients (r), limits of detection (LOD) and limits of quantitation (LOQ) were calculated. The slopes are used as a measure of the sensitivity of the proposed method, while the intercepts are used as a measure of the interfering background, (Table 3) . Results indicate high sensitivity and low background effect in ferric hydroxamate method.
Stoichiometric study
Using job's method of continuous variation, the molar ratio of ferric chloride to each of the hydroxamates of investigated drugs was 1:3.
Determination of stability constant
The stability constants of the ferric hydroxamates of investigated drugs were calculated using the following equation. 49 
K s = (A/A ex C x ) /C M -A/A ex C x )
(C L -nA/A ex C x ) n Where: K s is the stability constant of the formed product. N = X/(1-X) where X is the mole fraction of the ligand at the maximum of the continuous variation curve. A/A ex is the ratio of the observed absorption to that indicated by the tangent for the same wavelength. C M is the molar concentration of the metal. C L is the molar concentrations of the ligand. C x = C L /n. The calculated stability constants for the formed ferric hydroxamates of the investigated drugs ranged from 6.8 x 10 6 to 27.1 x 10 6 indicating good stability of the studied chelates. The high stability constants of the formed products may account for their high absorption intensity. The calculated stability constants are in good correlation with the measured absorption intensities of the studied products.
Effect of excipients
The assay results obtained by the proposed method were unaffected by the presence of commonly used excipients. No interference was observed from exipients such as starch, talc, sucrose and magnesium stearate.
Suggested reaction mechanism
The mechanism of reaction is thus based on the interaction between the sulphamoyl group of the chosen drug and hydroxylamine hydrochloride in alkaline medium to form corresponding hyroxamate and subsequent chelation of the resulting hydroxamates with iron (III) ions in acid medium to give red coloured products. The reaction mechanism should be suggested depending on the obtained molar ratio and previous reports, Scheme I.
Analysis of pharmaceutical dosage forms
The obtained high intensity absorption bands and the very low background make this method suitable for the routine quality control analysis of the investigated compounds with no interference from common additives. The proposed and Scheme I: Suggested mechanism for the reaction of studied drugs with hydroxylamine followed by ferric chloride.
reported methods were applied to the determination of the studied drugs in tablets ( Table 4 ). The t-and F-testes showed no significant differences between the calculated and theoretical values (95% confidence) of both the proposed and reported methods. This finding indicates similar precision and accuracy. The tabulated values of t and F at 95% confidence limit are t = 2.23 and F = 5.05
Method II
The interaction of most studied drugs, bendroflumethiazide, benzthiazide, chlorthalidone, clopamide, hydrochlorothiazide, indapamide and xipamide with potassium ferricyanide in acidic aqueous medium gave a bluish green coloured product with a strong absorption maximum at 720 nm. The absorption spectrum of the interaction product of potassium ferricyanide with xipamide as a representative example for the studied drugs is shown in Figure 8 .
Factors affecting color development
A preliminary investigation was carried out to determine the optimum conditions for the color formation for the studied drugs.
Effect of sodium hydroxide concentration
The absorption intensity increases by increasing concentration of sodium hydroxide and reaches its maximum value at 1.0 mL of 8.0 M per 10 mL of final solution, after which no further increase was observed ( Fig.9 ). 
Volume of 8.0 M sodium hydroxide (mL) Absorbance
Hydrochlorothiazide (4) Bendoflumethiazide (4) Clopamide (4) Benzthiazide (4) Xipamide (8) Chlorthalidone (10) Indapamide (10) Fig. 9 : Effect of sodium hydroxide concentration on the reaction between the investigated drugs (µg/ml) and potassium fericyanide reagent.
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Effect of potassium ferricyanide concentration
The absorption intensity increases by increasing concentration of potassium ferricyanide and reaches its maximum value at 1.0 mL of 0.01 M per 10 mL of final solution, after which no further increase occurs. Higher concentrations are not recommended to avoid high absorption intensity of the reagent blank (Fig. 10) .
Effect of temperature
The intensity of absorption of the coloured products increases on increasing temperature of heating with sodium hydroxide and potassium ferricyanide. The best result was at boiling point ( Fig. 11) .
Effect of heating time
The intensity of absorption of the coloured products increases on increasing time of heating on boiling water bath with sodium hydroxide and potassium ferricyanide. Optimum heating time was attained after 45 minutes for all of the studied drugs ( Fig. 12 ).
Effect of hydrochloric acid concentration
The absorption intensity of the resulting products increases by increasing concentration of hydrochloric acid and reaches its maximum value at 1.0 mL of 8.0 M per 10 mL of final solution, after which the absorption intensity decreases. Higher concentrations are not recommended because the reaction completely depends upon hydrogen ion concentration (Fig. 13) .
Effect of development time
The reaction time after neutralization was determined by following the color development at room temperature (25 ± 5°) at 720 nm. The reaction of potassium ferricyanide with each of the studied drugs exhibits higher color intensity when the reaction mixture was diluted to volume directly before measurement. Optimum reaction time was attained after 20 minutes for all of the studied drugs and the color remained stable for further 15 minutes for all of the studied drugs ( Fig. 14) .
Stoichiometric study
Using job's method of continuous variation, the molar ratio of potassium ferricyanide to each of the investigated drugs was 3:1.
Suggested reaction mechanism
It is well known that thiazide and thiazide-like diuretics hydrolyze easily specially in alkaline medium. 53&54 For instance, hydrochlorothiazide hydrolyzes to yield formaldehyde and 4-amino-6chlorobenzene-1,3-disulphonamide as shown in the following equation: 
Absorbance
Hydrochlorothiazide (4) Bendoflumethiazide (4) Clopamide (4) Benzthiazide (4) Xipamide (8) Chlorthalidone (10) Indapamide ( Te mpe rature
Hydrochlorothiazide (4) Bendroflumethiazide (4) Clopamide (4) Benzthiazide (4) Xipamide (8) Chlorthalidone (10) Indapamide (10) Fig. 11 : Effect of temperature on the reaction between the investigated drugs (µg/ml) and potassium ferricyanide reagent. Bendoflumethiazide (4) Clopamide (4) Benzthiazide (4) Xipamide (8) Chlorthalidone (10) Indapamide (10) 
Volume of 8.0 M hydrochloric acid (mL) Absorbance
Hydrochlorothiazide (4) Bendoflumethiazide (4) Clopamide (4) Benzthiazide (4) Xipamide (8) Chlorthalidone (10) Indapamide ( 
Development time (min) Absorbance
Hydrochlorothiazide (4) Bendoflumethiazide (4) Clopamide (4) Benzthiazide (4) Xipamide (8) Chlorthalidone (10) Indapamide ( This is a reversible reaction and in the presence of ferricyanide that oxidizes formaldehyde, the reaction is drawn to the right and complete hydrolysis can occure, that is why ferricyanide is added with alkali during hydrolysis. HCHO This addition product which is very similar to one of impurities found in hydrochlorothiazide (B.P) is oxidized under the influence of ferricyanide to the following dye, which is the chromogen being measured in the proposed assay: 
Method III
The investigated thiazide and thiazide-like diuretics have weak native fluorescence. However in this work, the investigated drugs (bendroflumethiazide, hydrochlorothiazide, hydroflumethiazide and clopamide) reacted with 4-chloro-7nitrobenzofurazan to give 4disubstituted amino-7-nitrobenzofurazan (yellow fluorescence) and can be measured at (excitation at 470 nm and emission at 535 nm). Neither 4chloro-7-nitrobenzofurazan nor any of the studied drugs has excitation and emission at these wavelengths. Figure (15) shows the excitation and emission spectra of the interaction product of hydrochlorothiazide as a representative example and 4-chloro-7-nitrobenzofurazan.
Factors affecting color development
A preliminary investigation was carried out to determine the optimum conditions for the fluorophore formation for the studied drugs.
Effect of heating temperature
The relative fluorescence intensity of the resulting products increases on increasing temperature of heating of the drug with 4-chloro-7-nitrobenzofurazan to form yellow fluorescence. Optimum temperature was found to be 65° for all of the studied drugs ( Fig. 16) .
Effect of heating time
The relative fluorescence intensity of the resulting products increases on increasing time of heating of the drug with 4-chloro-7-nitrobenzofurazan to form yellow fluorescence. Optimum heating time for all of the studied drugs was 45 minutes (Fig. 17 ).
Effect of 4-chloro-7-nitrobenzofurazan concentration
The relative fluorescence intensity of the interaction products increases by increasing concentration of 4chloro-7-nitrobenzofurazan and reaches its maximum value at 1.0 mL after which no further increase was observed. Higher concentrations are not recommended (Fig. 18 ). Temperature RFI Hydrochlorothiazide (4) Hydroflumethiazide (4) Bendroflumethiazide (4) Clopamide (8) Fig. 16 : Effect of temperature on the reaction between the studied drugs (µg/ml) and NBD-Cl in ethanol. Heating time (min)
RFI
Hydrochlorothiazide (4) Hydroflumethiazide (4) Bendroflumethiazide (4) Clopamide ( Volume of NBD-Cl re age nt (mL)
Hydrochlorothiazide (4) Hydroflumethiazide (4) Bendroflumethiazide (4) Clopamide (8) Fig. 18 : Effect of NBD-Cl concentration on the reaction between the studied drugs (µg/ml) and NBD-Cl in ethanol.
Effect of diluting solvent
The effect of various solvents of different polarities on the relative fluorescence intensities of the formed products was studied. Ethanol was found to be an ideal solvent for the formation of 4-disubstituted-7-nitrobenzofurazan. Methanol, dimethylformamide, dimethylsulphoxide and water gave lower relative fluorescence intensities.
Stoichiometric study
Using job's method of continuous variation, the molar ratio of 4-chloro-7-nitrofurazan to each of the investigated drugs was 1:1.
Suggested reaction mechanism
The mechanism of reaction is based on the interaction between the secondary amine moiety of the chosen drugs and NBD-Cl to form yellow fluorescent products as shown in scheme II.
Conclusion
The proposed methods are simple, rapid and more sensitive than the official methods. Moreover, they can be applied to the quality control analysis of the studied drugs either in pure form or in combined dosage forms without interference. In addition to spectrophotometry and spectroflurimetry, infrared and 1 HNMR spectroscopy could also be used to study the possible site of interaction between hydroxylamine and the investigated drugs. Scheme II: Suggested reaction mechanism for the reaction of studied drugs with NBD-Cl.
Yellow flourescent product 4-Chloro-7-nitrobenzofurazan
